N-Glycosylation of Antibodies: Biological Effects During Infections and Therapeutic Applications
Antibodies · 28.10.2025 · 14 (4) · 93
DOI: 10.3390/antib14040093 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibodies, online erschienen am 28.10.2025. Verfasst von Jessica Castañeda-Casimiro und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas (ENCB), Instituto Politécnico Nacional (IPN), Mexico City 11340, Mexico. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Secretaría de Ciencia, Humanidades, Tecnología e Innovación, Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional, SECIHTI fellowships.
Abstract (Originalsprache)
Antibodies are produced by cells of the adaptive immune response and recognize epitopes of microbial structures with high affinity and specificity. Antibodies are recognized by Fc fragment receptors (FcRs) found on the surface of phagocytic cells (neutrophils, monocytes, macrophages) and NK cells, among others. Hence, antibodies link the adaptive immune response with the innate immune response. The functions of antibodies are related to the N-glycosylation profile of these proteins. In this review, we describe how N-glycosylation of the Fc fragment of the different antibody classes is carried out, and which oligosaccharides are most commonly found in these antibodies. Subsequently, we summarize the biological effects of N-glycosylation of antibodies: on the binding of antibodies to FcRs (which affects various functions, such as antibody-dependent cellular cytotoxicity, antibody-dependent phagocytosis, and the production of pro- or anti-inflammatory chemokines and cytokines), on the ability of antibodies to activate complement and on the ability of some antibodies to directly neutralize the adhesion of bacteria and viruses to host cells (independently of Fab recognition). We describe how the N-glycosylation profile of antibodies is modified during certain infections (such as tuberculosis, COVID-19, influenza and dengue) and in response to vaccination, and the potential use of this profile to identify the stage and severity of an infection. Finally, we review the importance of N-glycosylation for the pharmacokinetic, pharmacodynamic and safety profiles of therapeutic monoclonal antibodies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Departamento de Inmunología, Escuela Nacional de Ciencias Biológicas (ENCB), Instituto Politécnico Nacional (IPN), Mexico City 11340, Mexico.
- Unidad de Desarrollo e Investigación en Bioterapéuticos (UDIBI), Escuela Nacional de Ciencias Biológicas (ENCB), Instituto Politécnico Nacional (IPN), Mexico City 11340, Mexico.
- Laboratorio Nacional para Servicios Especializados de Investigación, Desarrollo e Innovación (I+D+i) para Farmoquímicos y Biotecnológicos, LANSEIDI-FarBiotec-CONAHCYT, Mexico City 11340, Mexico.
- Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), Mexico City 04360, Mexico.
- Servicio de Neumología del Hospital General de México "Dr. Eduardo Liceaga", Secretaría de Salud, Mexico City 06720, Mexico.
- Departamento de Bioquímica, Escuela Nacional de Ciencias Biológicas (ENCB), Instituto Politécnico Nacional (IPN), Mexico City 11340, Mexico.
ORCID-Profile: Luis Vallejo-Castillo, Isabel Wong-Baeza
Förderung
- Secretaría de Ciencia, Humanidades, Tecnología e Innovación
- Secretaría de Investigación y Posgrado, Instituto Politécnico Nacional
- SECIHTI fellowships
Zitieren
APA
Castañeda-Casimiro, J., Vallejo-Castillo, L., Peregrino, E. S., Hernández-Solis, A., Vázquez-Flores, L., Chacón-Salinas, R., Wong-Baeza, I., & Serafín-López, J. (2025). N-Glycosylation of Antibodies: Biological Effects During Infections and Therapeutic Applications. Antibodies, 14(4), 93. https://doi.org/10.3390/antib14040093
Vancouver
Castañeda-Casimiro J, Vallejo-Castillo L, Peregrino ES, Hernández-Solis A, Vázquez-Flores L, Chacón-Salinas R, et al. N-Glycosylation of Antibodies: Biological Effects During Infections and Therapeutic Applications. Antibodies. 2025;14(4):93. doi:10.3390/antib14040093
BibTeX
@article{CastaedaCasimiro2025,
author = {Castañeda-Casimiro, Jessica and Vallejo-Castillo, Luis and Peregrino, Eliud S and Hernández-Solis, Alejandro and Vázquez-Flores, Luis and Chacón-Salinas, Rommel and Wong-Baeza, Isabel and Serafín-López, Jeanet},
title = {N-Glycosylation of Antibodies: Biological Effects During Infections and Therapeutic Applications},
journal = {Antibodies},
year = {2025},
volume = {14},
number = {4},
pages = {93},
doi = {10.3390/antib14040093}
}
EUVIMED